转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2026-001 武汉华康世纪洁净科技股份有限公司 关于收到中标通知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 武汉华康世纪洁净科技股份有限公司（以下简称"公司"）于 2025 年 12 月 24 日在创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）上披露了《关于 项目预中标的提示性公告》（公告编号：2025-143）。近日，公司收到采购代理 机构泉州市工程建设监理事务所有限责任公司发出的《福建省政府采购中标通知 书》，确认公司与上海市安装工程集团有限公司组成的联合体（以下简称"联合 体"）为"惠安县医院分院（一期工程）医院特殊科室采购项目（采购包 1）" 的中标供应商。现将中标项目的主要内容公告如下： 一、中标项目基本情况 1、建设地点：惠安县惠西片区紫山镇光山村、美仁村，亮亮中学对面。 2、中标范围：本工程为福建惠安县医院分院特殊科室采购项目，共涉及急 诊手术室 EICU、检验科、输血科、门诊手术室、妇科手术室、内镜中心、供应 ...

Group 1 - Aerospace Power's main business does not involve commercial aerospace, nor does it have any commercial aerospace-related assets for external investment [1] - Daye Co., Ltd.'s robotic tendon products are still in the exploratory testing phase and have not yet achieved mass production [1] Group 2 - Zhongyan Chemical plans to invest 83.9692 million yuan to expand its production capacity to 10,000 tons of metallic sodium and 15,500 tons of liquid nitrogen annually [1] - Huakang Clean has won the bid for the construction of the laboratory process project (Phase I, first opening area) in Dalian Yinggeshi Science City [1] Group 3 - Lixun Precision intends to repurchase shares worth between 1 billion to 2 billion yuan [1] - Green Island Wind's actual controller's concerted actors plan to reduce their holdings by no more than 1% of shares [1] Group 4 - Guangku Technology expects a year-on-year net profit increase of 152.00% to 172.00% in 2025 [1] - Zhaoli Technology is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [1]

Group 1: Company Highlights - Aerospace Power (航天动力) does not engage in commercial aerospace business and has no investments in commercial aerospace assets [3] - Daye Co., Ltd. (大业股份) is still in the exploratory phase for its robotic tendon products and has not achieved mass production [3] - Guangku Technology (光库科技) expects a year-on-year net profit increase of 152.00% to 172.00% in 2025 [4] Group 2: Project Investments - Zhongyan Chemical (中盐化工) plans to invest 83.9692 million yuan to expand its production capacity to 10,000 tons of sodium metal and 15,500 tons of liquid chlorine [3][4] - Shennma Power (神马电力) is establishing a new company in Vietnam to invest in a digital factory for new materials for the power grid [3] - New Zobang (新宙邦) intends to invest in the second phase of its lithium-ion battery materials project in Poland and also plans a project in the Middle East [3] Group 3: Contracts and Acquisitions - Huakang Clean (华康洁净) has won the bid for the construction of the laboratory process project in Dalian Yinggeshi Science City [3] - Xidi Micro (希荻微) plans to acquire 100% of Chengxin Micro for 310 million yuan [3] - Hai Li Biological (海利生物) intends to acquire 51% stakes in seven dental chain companies in Yangzhou and Changzhou [3] Group 4: Share Buybacks and Holdings - Luxshare Precision (立讯精密) plans to repurchase shares worth between 1 billion to 2 billion yuan [3] - Jiazhe New Energy (嘉泽新能) intends to spend between 22 million to 44 million yuan on share buybacks [3] - Dagang Holdings (达刚控股) plans to repurchase shares worth between 20 million to 40 million yuan [3] Group 5: Shareholding Changes - Green Island Wind (绿岛风) has a shareholder planning to reduce their stake by no more than 1% [3] - Lingzhi Software (凌志软件) has a shareholder intending to reduce their holdings by up to 3.281 million shares [4]

人民财讯12月31日电，华康洁净（301235）12月31日公告，公司中标"大连英歌石科学城实验室工艺项 目(一期首开区)二标段施工"项目，中标价格9417.17万元。该项目中标后的实施，预计对公司未来经营 业绩产生积极影响。 ...

格隆汇12月31日丨华康洁净(301235.SZ)公布，公司于近日参与了"大连英歌石科学城实验室工艺项目(一 期首开区)二标段施工"项目的投标，招标单位为大连英歌石科技产业发展有限公司。2025年12月31日， 辽宁建设工程信息网发布了相关中标结果公示。中标价格：94,171,677.82元。 ...

格隆汇12月31日丨华康洁净(301235.SZ)公布，公司于近日参与了"大连英歌石科学城实验室工艺项目(一 期首开区)二标段施工"项目的投标，招标单位为大连英歌石科技产业发展有限公司。2025年12月31日， 辽宁建设工程信息网发布了相关中标结果公示。中标价格：94,171,677.82元。 ...

转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2025-145 武汉华康世纪洁净科技股份有限公司 关于项目中标的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 2、招标代理机构名称：大连市机电设备招标有限责任公司 3、项目标段名称：大连英歌石科学城实验室工艺项目(一期首开区)二标段 施工 4、中标人名称：武汉华康世纪洁净科技股份有限公司 5、中标价格：94,171,677.82 元 6、公示媒体：辽宁建设工程信息网（http://218.60.147.115/） 二、中标事项对公司业绩的影响 该项目中标后的实施，预计对公司未来经营业绩产生积极影响，其合同的履 特别提示：截至本公告披露之日，武汉华康世纪洁净科技股份有限公司（以 下简称"公司"）尚未取得中标通知书，签约等后续工作尚具有一定不确定性， 敬请广大投资者注意投资风险。公司将根据相关事项后续进展情况履行相应的信 息披露义务。 公司于近日参与了"大连英歌石科学城实验室工艺项目(一期首开区)二标段 施工"项目的投标，招标单位为大连英歌石科技产业发 ...

证券日报网讯 12月31日，华康洁净在互动平台回答投资者提问时表示，公司电子洁净室业务作为公司 重要的战略发展方向，正积极有序地推进市场开拓与客户合作。关于该业务的经营数据及客户合作情 况，请以公司在法定信息披露媒体和官方平台发布的内容为准。 （文章来源：证券日报） ...

12月31日，华康洁净盘中下跌2.02%，截至13:58，报36.80元/股，成交1.52亿元，换手率5.60%，总市值 39.66亿元。 分红方面，华康洁净A股上市后累计派现4002.14万元。近三年，累计派现2946.14万元。 机构持仓方面，截止2025年9月30日，华康洁净十大流通股东中，富国优化增强债券A/B（100035）位 居第六大流通股东，持股180.00万股，为新进股东。富国久利稳健配置混合型A（003877）位居第九大 流通股东，持股49.78万股，为新进股东。招商量化精选股票发起式A（001917）位居第十大流通股东， 持股47.00万股，为新进股东。安信医药健康股票A（010709）、诺安多策略混合A（320016）退出十大 流通股东之列。 责任编辑：小浪快报 资料显示，武汉华康世纪洁净科技股份有限公司位于湖北省武汉市东湖新技术开发区高新大道718号3 栋，成立日期2008年11月12日，上市日期2022年1月28日，公司主营业务涉及医疗净化系统研发、设 计、实施和运维,相关医疗设备和医疗耗材的销售。主营业务收入构成为：净化系统集成85.24%，医疗 耗材销售8.53%，医疗设备销售3 ...

Core Viewpoint - Huakang Clean has experienced significant stock price fluctuations, with a year-to-date increase of 90.32% but a recent decline of 13.23% over the past five trading days [1] Group 1: Stock Performance - As of December 30, Huakang Clean's stock price is 38.37 yuan per share, with a market capitalization of 4.135 billion yuan [1] - The stock has seen a trading volume of 50.0591 million yuan and a turnover rate of 1.78% [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1] Group 2: Financial Performance - For the period from January to September 2025, Huakang Clean achieved a revenue of 1.431 billion yuan, representing a year-on-year growth of 32.59% [2] - The net profit attributable to shareholders for the same period was 61.1567 million yuan, showing a substantial increase of 211.46% year-on-year [2] Group 3: Business Overview - Huakang Clean, established on November 12, 2008, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of the company includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 4: Shareholder Information - As of December 19, the number of Huakang Clean's shareholders increased to 10,700, a rise of 3.08% from the previous period [2] - The average number of tradable shares per shareholder is 6,802, which has decreased by 2.99% [2] - New institutional shareholders include Fuguo Optimized Enhanced Bond A/B and Fuguo Jiuli Steady Allocation Mixed A, among others [3]